Course Overview
Emerging Strategies and New Mechanisms of Action in the Prophylaxis of Venous Thromboembolism in Orthopaedic Surgery
The American Medical Association has determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRA Category 1 Credit ™.
Overview: This 60-minute interactive Webcast, geared toward an audience of European orthopaedic surgeons, focuses on current and emerging strategies related to assessment and selection of appropriate thromboprophylactic treatment for orthopaedic surgery patients. Selected sessions from the International Society on Thrombosis and Haemostasis (ISTH) Congress are the foundation for the educational activity, which is composed of concise faculty presentations and discussions that focus on the interpretation and translation of new science to everyday clinical practice for European practitioners.
Faculty
Jay R. Lieberman, MD
Director, New England Musculoskeletal Institute
Professor and Chairman
Department of Orthopaedic Surgery
University of Connecticut Health Center
Farmington, Connecticut, United States
Michael Rud Lassen, MD
Spine Clinic and Clinical Trial Unit
Hørsholm Hospital
University of Copenhagen
Hørsholm, Denmark
Robert A. Harrington, MD
Professor of Medicine
Director, Duke Clinic Research Institute
Durham, North Carolina, United States
Credits available: A maximum of 1.0 AMA PRA Category 1 Credit™
Types of credit available:
AMA PRA Category 1 Credit™
Expires: 10/6/10
This activity has been approved for AMA PRA Category 1 Credit™
Supported by an educational grant from:
Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or e-mail info@med-iq.com. For technical assistance, please refer to our support manual.
Bookmark These Med-IQ Sites
Med-IQ Specialty Sites
